Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Accepts healthy volunteers Results available

A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults

ClinicalTrials.gov ID: NCT05827926

Public ClinicalTrials.gov record NCT05827926. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 5:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1/2, Randomized, Observer-blind, Active-Control Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-based Influenza and SARS-CoV-2 Multi-component Vaccines in Healthy Adults

Study identification

NCT ID
NCT05827926
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
ModernaTX, Inc.
Industry
Enrollment
1,758 participants

Conditions and interventions

Interventions

  • Influenza Vaccine 1 Biological
  • mRNA-1083.1 Biological
  • mRNA-1083.2 Biological
  • mRNA-1083.3 Biological
  • Investigational Influenza Vaccine 1 Biological
  • Investigational COVID-19 Vaccine 1 Biological
  • COVID-19 Vaccine 1 Biological
  • Investigational Influenza Vaccine 2 Biological
  • Influenza Vaccine 2 Biological
  • mRNA-1083 Biological
  • Investigational COVID-19 Vaccine 2 Biological
  • COVID-19 Vaccine 2 Biological

Biological

Eligibility (public fields only)

Age range
18 Years to 79 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 13, 2023
Primary completion
Dec 2, 2024
Completion
Dec 2, 2024
Last update posted
Dec 22, 2025

2023 – 2024

United States locations

U.S. sites
69
U.S. states
27
U.S. cities
62
Facility City State ZIP Site status
Chandler Clinical Trials Chandler Arizona 85224-6231
Benchmark Research Colton California 92324
Marvel Clinical Research Huntington Beach California 92647-6835
Central Valley Research Modesto California 95350-5365
Benchmark Research Sacramento California 95864-3102
Tekton Research Longmont Colorado 80501-6461
Accel Research Sites DeLand Florida 32720-0834
CenExel Hollywood Florida 33024
Nature Coast Clinical Research Inverness Florida 34452
Jacksonville Center For Clinical Research Jacksonville Florida 32216
Accel Research Sites Maitland Florida 32751
Suncoast Research Group Miami Florida 33135-1687
Centricity Research Columbus Georgia 31904
Accel Research Site Decatur Georgia 30030-2615
CenExel iResearch Decatur Georgia 30030
Lifeline Primary Care Lilburn Georgia 30047-2832
Koch Family Medicine Morton Illinois 61550
Optimal Research Peoria Illinois 61614-4885
DM Clinical Research River Forest Illinois 60305-1876
Johnson County Clin-Trials Lenexa Kansas 66219-1389
Tekton Research Wichita Kansas 67218-2913
Versailles Family Medicine Versailles Kentucky 40383-1947
Velocity Clinical research Baton Rouge Louisiana 70809
Benchmark Research Metairie Louisiana 70006
DelRicht Research New Orleans Louisiana 70115
DelRicht Research Prairieville Louisiana 70769
Annapolis Internal Medicine Annapolis Maryland 21401
Velocity Clinical Research Rockville Maryland 20854
DM Clinical Research Brookline Massachusetts 02445-7113
Vida Clinical Studies Dearborn Heights Michigan 48127-2234
DelRicht Research Gulfport Mississippi 39503
Clay Platte Family Medicine Kansas City Missouri 64151-2411
Velocity Clinical Research Lincoln Nebraska 68510
Velocity Clinical Research Norfolk Nebraska 68701
Excel Clinical Research Las Vegas Nevada 89109-6209
CCT Research Las Vegas Nevada 89119
Las Vegas Clinical Trials North Las Vegas Nevada 89030-7193
Rochester Clinical Research Rochester New York 14609-3169
Tryon Medical Partners Charlotte North Carolina 28210
Trial Management Associates Wilmington North Carolina 28403-6238
CTI Clinical Research Center Cincinnati Ohio 45212
Velocity Clinical Research Cincinnati Ohio 45219
Velocity Clinical Research Cincinnati Ohio 45246
Centricity Research Columbus Ohio 43213
WellNow Urgent Care & Research Dayton Ohio 45424-4019
Lynn Institute of East Oklahoma Oklahoma City Oklahoma 73111-3324
DelRicht Research Tulsa Oklahoma 74133
Tekton Research Inc Yukon Oklahoma 73099-9518
DM Clinical Research Philadelphia Pennsylvania 19107-1530
Mercado Medical Practice Philadelphia Pennsylvania 19111-2432
DelRicht Research Charleston South Carolina 29407
Trial Management Associates Myrtle Beach South Carolina 29572-4612
Medical Care Elizabethton Tennessee 37643
DelRicht Research Hendersonville Tennessee 37075
Benchmark Research Austin Texas 78705-3298
Tekton Research Austin Texas 78745-1470
Tekton Research Beaumont Texas 77706-3061
Benchmark Research Fort Worth Texas 76135
Cyfair Clinical Research Houston Texas 77065
Texas Center for Drug Development Houston Texas 77081
DelRicht Research McKinney Texas 75070
Benchmark Research San Angelo Texas 76904-7610
Tekton Research San Antonio Texas 78229
CCT Research Pleasant View Utah 84404
Ogden Clinic Roy Utah 84067
JBR Clinical Research Salt Lake City Utah 84107
Meridian Clinical Research Hampton Virginia 23666
Velocity Clinical Research Portsmouth Virginia 23703
Wenatchee Valley Hospital & Clinics Campus Wenatchee Washington 98801

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05827926, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 22, 2025 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05827926 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →